Sex: M
Vaccine: COVID19, COVID19, UNK
Symptoms: Fatigue, Flushing, Pain in extremity, Psoriasis, Upper respiratory tract congestion
Clinical narrative: INCREASED UPPER RESPIRATORY TRACT CONGESTION; STILL HAD SOME QUARTER SIZED PLAQUE FROM PLAQUE PSORIASIS WITH DRY SKIN; flush for 12 hours; fatigue and sore arm for four to five days; fatigue and sore arm for four to five days; This spontaneous case was reported by a consumer and describes the occurrence of UPPER RESPIRATORY TRACT CONGESTION (INCREASED UPPER RESPIRATORY TRACT CONGESTION), PSORIASIS (STILL HAD SOME QUARTER SIZED PLAQUE FROM PLAQUE PSORIASIS WITH DRY SKIN), FLUSHING (flush for 12 hours), PAIN IN EXTREMITY (fatigue and sore arm for four to five days) and FATIGUE (fatigue and sore arm for four to five days) in an adult male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect products included non-company products TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for COVID-19 vaccination and RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) for Plaque psoriasis.    Concurrent medical conditions included Psoriasis.   On 11-Mar-2021, the patient received first dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (Intramuscular) 1 dosage form. On 01-Apr-2021, received second dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (Intramuscular) dosage was changed to 1 dosage form. On 02-Sep-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced UPPER RESPIRATORY TRACT CONGESTION (INCREASED UPPER RESPIRATORY TRACT CONGESTION), PSORIASIS (STILL HAD SOME QUARTER SIZED PLAQUE FROM PLAQUE PSORIASIS WITH DRY SKIN), FLUSHING (flush for 12 hours), PAIN IN EXTREMITY (fatigue and sore arm for four to five days) and FATIGUE (fatigue and sore arm for four to five days). At the time of the report, UPPER RESPIRATORY TRACT CONGESTION (INCREASED UPPER RESPIRATORY TRACT CONGESTION) and PSORIASIS (STILL HAD SOME QUARTER SIZED PLAQUE FROM PLAQUE PSORIASIS WITH DRY SKIN) had not resolved and FLUSHING (flush for 12 hours), PAIN IN EXTREMITY (fatigue and sore arm for four to five days) and FATIGUE (fatigue and sore arm for four to five days) had resolved.            No concomitant medications were reported.  It was unknown if patient was enrolled in a COVID-19 Vaccine Trial.  The patient had upper respiratory involvement and increased congestion. The Skyrizi was less effective than hoped and still had some plaques quarter sized with dry skin. After covid-19 vaccination patient had flush for 12 hours, fatigue and sore arm for four to five days. The reporter causality for the events Upper respiratory tract congestion and Drug ineffective with SKYRIZI was a reasonable possibility and events Plaque psoriasis, Flushing, Pain in arm and Fatigue with SKYRIZI was not provided. The reporter causality for the events Upper respiratory tract congestion, Plaque psoriasis, Flushing, Pain in arm, Fatigue and Drug ineffective with PFIZER was reported as possible.  No treatment information was reported.